Viswam S. Nair
Academic Appointments
- Instructor, Medicine - Pulmonary & Critical Care Medicine
Key Documents
Contact Information
-
Clinical Offices
Chest Clinic 300 Pasteur Dr A283 MC 5351 Stanford, CA 94305 Tel Work (650) 725-7061 Fax (650) 498-6288
- Academic Offices
Alternate Contact Aashi Khanna Division Admin Email Tel Work 650.723.6381Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Pulmonary Disease
- Lung Cancer
- Solitary Pulmonary Nodule
- Intensive Care of the Medical Patient
Administrative Appointments
- Instructor of medicine, Stanford University, Div of PCCM (2012 - 2013)
- Post-doctoral reseach fellow and clinical instructor, Stanford University, Division of Pulmonary & Critical Care (2010 - 2012)
Honors and Awards
- In vivo and in vitro diagnostics for assessing the lung nodule, LUNGevity Foundation Career Development Award (07/12-07/15)
- An analysis of early-stage NSCLC transcriptomics across varying FDG uptake levels on PET imaging, Lung Cancer Research Foundation (11/10-11/11)
- PET-FDG uptake, gene expression and outcome in stage I resected lung adenocarcinoma, The CHEST Foundation, Clinical Research Award (07/09-07/10)
Professional Education
| Fellowship: | Stanford University Division of PCCM CA (6/2010) |
| Residency: | Santa Clara Valley Medical Center, CA USA (6/2007) |
| Medical Education: | Ohio State University OH (6/2004) |
| Board Certification: | Pulmonary Disease, American Board of Internal Medicine (2009) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2007) |
Internet Links
Scientific Focus
Current Research Interests
My research interests are centered on improving care for the lung cancer patient by enhancing current clinical models of risk for benign and malignant solitary pulmonary nodules with molecular data. FDG PET uptake serves as the focus of my efforts to better understand tumor metabolism across multiple platforms and thereby augment clinical accumen. Additionally, I am interested in understanding the current limitations of -omics and biomarker studies in clinical practice, thereby facilitating improved diagnostic and prognostic tests for the lung cancer patient.
Publications
- Circulating tumour cells in early breast cancer. Lancet Oncol. 2012; (9): e370-1; author reply e371
- Clinical outcome prediction by microRNAs in human cancer: a systematic review. J Natl Cancer Inst. 2012; (7): 528-40
- Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer. Cancer Res. 2012; (15): 3725-34
- Fluorodeoxyglucose-PET scanning in the diagnosis of pleural disease. Chest. 2011; (4): 966-7; author reply 967
- Management of lung nodules detected by volume CT scanning. N Engl J Med. 2010; (8): 757; author reply 758-9
- PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest. 2010; (5): 1150-6
Help